The FRET method is used to inhibit the HIV1 protease Q7K mutant through a direct single protein target. The assay organism is Human Immunodeficiency Virus 1, and the assay type is Binding. The variant sequence, consisting of the accession number O90781, the mutation Q7K, and the organism Human Immunodeficiency Virus, is PQVTLWKRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLIGPTPVNIIGRNLLTQIGCTLNF, with a tax ID of 12721 and version 1. Does this molecule show effectiveness in this assay?